US Stock MarketDetailed Quotes
BMEA Biomea Fusion
- 4.270
- +0.260+6.48%
Close Jan 8 16:00 ET
- 4.200
- -0.070-1.64%
Post 19:59 ET
154.74MMarket Cap-1.06P/E (TTM)
4.320High3.800Low1.18MVolume3.950Open4.010Pre Close4.92MTurnover5.27%Turnover RatioLossP/E (Static)36.24MShares20.21052wk High2.04P/B95.88MFloat Cap3.61052wk Low--Dividend TTM22.46MShs Float43.690Historical High--Div YieldTTM12.97%Amplitude2.840Historical Low4.153Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Biomea Fusion Stock Forum
Icovamenib, in combination with semaglutide, approximately doubled C-peptide production per unit of glucose compared to semaglutide alone leading to a 60% improved reduction of fasting blood glucose
Ex vivo human islet experiments pr...
Biomea Fusion Reports New Preclinical Data on Icovamenib-Semaglutide Combination Study Thanks @Jaguar8 For spotting since for some reason they say no more posts???
Icovamenib met the primary endpoint, displaying a meaningful statistically significant placebo-corrected mean reduction in HbA1c in the prespecified per protocol patient population
Icovamenib was well-tolerated, with no adverse-event related discontinuations, no hypoglycemic events and no serious adverse events
Yet all the analysts are giving target price from a low 11$ to a 50/60 and above.
What's your take?
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
$KULR Technology (KULR.US)$ PR 12/17: Signs Service Agreement to Launch KULR ONE Space Battery. COH $13.4M good for 9 months✅
$Wearable Devices (WLDS.US)$ PR 12/17:...
No comment yet